CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ÀÌÀ¯È£
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ½ÅÀåÀ̽Ä/±Þ¼º½ÅÁúȯ/¸¸¼º½ÅÁúȯ/Ç÷´¢/´Ü¹é´¢/Åõ¼®
  • Á÷ À§: Á¶±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
44 (±¹¿Ü)±âŸ the relationship between thyroid hormone levels and corrected QT interval and QT dispersion in non-diabetic hemodialysis patients
43 (±¹³»)KCI Åõ¼® ȯÀÚ¿¡¼­ Ç÷°ü ¼®È¸È­, µ¿¸Æ °æÁ÷, ¿°Áõ, ¿µ¾ç »óÅ¿ÍÀÇ »ó°ü°ü°è
42 (±¹¿Ü)SCI TGF-b Activated Kinase 1 Is Crucial in Podocyte Differentiation and Glomerular Capillary Formation
41 (±¹³»)KCI ±Þ¼º ½Å¼Õ»óÀ¸·Î ¹ßÇöµÈ ¹Ì¼¼ º¯È­ ½ÅÁõ¿¡ µ¿¹ÝµÈ ÀÚ°¡¸é¿ª °©»ó¼±¿°
40 (±¹³»)KCI ´Ü¹é´¢ÀÇ °¨º°Áø´Ü ¹× Ä¡·á
39 (±¹¿Ü)SCI Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-¥â signaling.
38 (±¹³»)SCIE Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients
37 (±¹³»)SCOPUS Åõ¼®È¯ÀÚÀÇ BÇü°£¿° ¹ÙÀÌ·¯½º ÀáÀç°¨¿°·ü
36 (±¹¿Ü)SCI Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients
35 (±¹¿Ü)SCI TGF-¥â sensitivity is determined by N-linked glycosylation of the type II TGF-¥â receptor
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729